D. Alexandrescu

D. Alexandrescu, C. Dasanu, Demytra K Mitsis, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

A complex pattern of melanonychia and onycholysis after treatment with pemetrexed for lung cancer.

P. Wiernik, D. Alexandrescu, C. Dasanu, 2007, Skinmed.

H. pylori-Associated Gastric Cancer in a Husband-Wife Pair: A Veritable Family Affair

D. Alexandrescu, C. Dasanu, J. Rathmann, 2009, Southern medical journal.

Metastatic solid-pseudopapillary tumour of the pancreas: clinico-biological correlates and management.

P. Wiernik, D. Alexandrescu, K. O’Boyle, 2005, Clinical oncology (Royal College of Radiologists (Great Britain)).

Generalized cerebral atrophy seen on MRI in a naturally exposed animal model for creutzfeldt-jakob disease

A. McKnight, T. Ichim, Gary Smith, 2010, Journal of Translational Medicine.

Fatal Intra-Alveolar Hemorrhage After Rituximab in a Patient with non-Hodgkin Lymphoma

J. Dutcher, P. Wiernik, S. Oiseth, 2004, Leukemia & lymphoma.

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy

F. Marincola, J. Koropatnick, N. Riordan, 2014, Journal of Translational Medicine.

On the missing link between inflammation and cancer.

T. Ichim, N. Riordan, D. Alexandrescu, 2011, Dermatology online journal.

Multiple eruptive dermatofibromas occurring in a patient with chronic myelogenous leukemia.

P. Wiernik, D. Alexandrescu, 2005, Archives of dermatology.

Secondary erythrocytosis produced by the tyrosine kinase inhibitors sunitinib and sorafenib.

D. Alexandrescu, C. Dasanu, R. McClure, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cutaneous sarcoidosis and malignancy: An association between sarcoidosis with skin manifestations and systemic neoplasia.

T. Ichim, N. Riordan, D. Alexandrescu, 2011, Dermatology online journal.

Newer developments in the immunotherapy of malignant melanoma

T. Ichim, D. Alexandrescu, C. Dasanu, 2014, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

mTOR-blocking agents in advanced renal cancer: an emerging therapeutic option

D. Alexandrescu, C. Dasanu, B. Clark, 2009 .

Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): Report of three cases

J. Dutcher, P. Wiernik, D. Alexandrescu, 2005, American journal of hematology.

Circulating endothelial progenitor cells and erectile dysfunction: possibility of nutritional intervention?

T. Ichim, N. Riordan, J. Jackson, 2010, Panminerva Medica (Testo stampato).

Risk of additional cancers in untreated and treated hairy cell leukemia patients

D. Alexandrescu, C. Dasanu, 2010, Expert opinion on pharmacotherapy.

Inherent and iatrogenic immune defects in hairy cell leukemia: revisited

T. Ichim, D. Alexandrescu, C. Dasanu, 2010, Expert opinion on drug safety.

Polycystic Ovary Syndrome: Focus on Platelets and Prothrombotic Risk

T. Ichim, D. Alexandrescu, C. Dasanu, 2011, Southern medical journal.

Etanercept decreases the innate immune wounding response in psoriasis

R. Gallo, M. Afshar, T. Hata, 2013, Experimental dermatology.

Effect of treatment with a colloidal oatmeal lotion on the acneform eruption induced by epidermal growth factor receptor and multiple tyrosine‐kinase inhibitors

D. Alexandrescu, C. Dasanu, J. Vaillant, 2006, Clinical and experimental dermatology.

Unusual cutaneous involvement during plasma cell leukaemia phase in a multiple myeloma patient after treatment with thalidomide: a case report and review of the literature

P. Wiernik, P. Wiernik, D. Alexandrescu, 2005, Clinical and experimental dermatology.

Is Biochemotherapy the Future

J. Dutcher, P. Wiernik, D. Alexandrescu, 2005 .

Persistent hair growth during treatment with the EGFR inhibitor erlotinib.

D. Alexandrescu, C. Dasanu, C. L. Kauffman, 2009, Dermatology online journal.

Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.

N. Dawson, L. Wartofsky, D. Alexandrescu, 2008, Thyroid : official journal of the American Thyroid Association.

Development of squamous cell carcinomas in Darier disease: a new model for skin carcinogenesis?

D. Alexandrescu, C. Dasanu, C. L. Kauffman, 2008, The British journal of dermatology.

The cutaneous epidermal growth factor network: Can it be translated clinically to stimulate hair growth?

D. Alexandrescu, C. Dasanu, C. L. Kauffman, 2009, Dermatology online journal.

Muehrcke’s lines (Leukonychia striata) due to transretinoic acid therapy for acute promyelocytic leukemia

T. Ichim, D. Alexandrescu, C. Dasanu, 2013, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Pyoderma gangrenosum due to lenalidomide use for multiple myeloma

D. Alexandrescu, C. Dasanu, B. Bockorny, 2015, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Distinct patterns of chromonychia, Beau's lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma.

D. Alexandrescu, C. Dasanu, J. Vaillant, 2006, Dermatology online journal.

Comparative Results in Treatment of Keloids With Intralesional 5-FU/Kenalog, 5-FU/Verapamil, Enalapril Alone,Verapamil Alone, and Laser: A Case Report and Review of the Literature.

R. Fitzpatrick, M. Goldman, D. Alexandrescu, 2016, Journal of drugs in dermatology : JDD.

Lasers, stem cells, and COPD

Amit N. Patel, S. Josephs, E. Carrier, 2010, Journal of Translational Medicine.

Metastatic choriocarcinoma in a middle-aged man presenting as a right thigh mass with venous thrombosis

J. Dutcher, P. Wiernik, J. Fuks, 2003, Medical oncology.

Prophylactic antivirals may be helpful in prevention of varicella-zoster virus reactivation in myeloma, but are they safe?

D. Alexandrescu, C. Dasanu, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Expression of the Epigenetic factor BORIS (CTCFL) in the Human Genome

C. Chen, S. Josephs, A. Ghochikyan, 2011, Journal of Translational Medicine.

Kidney cancer therapy: new perspectives and avenues

D. Alexandrescu, C. Dasanu, 2006, Expert opinion on pharmacotherapy.

Bilateral Perinephric Diffuse Large B-Cell Lymphoma and Synchronous Renal Oncocytoma

D. Alexandrescu, C. Dasanu, 2008, Southern medical journal.

A phase II study of YM155 administered as 168 hour continuous infusion in stage IV and unresectable stage III melanoma.

J. Kirkwood, K. Lewis, W. Samlowski, 2007 .

Mesenchymal stem cells as anti-inflammatories: implications for treatment of Duchenne muscular dystrophy.

Fabian Lara, Amit N. Patel, Erik J Woods, 2010, Cellular immunology.

Does bortezomib induce de facto varicella zoster virus reactivation in patients with multiple myeloma?

D. Alexandrescu, C. Dasanu, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Yellow skin discoloration associated with sorafenib use for treatment of metastatic renal cell carcinoma.

J. Dutcher, D. Alexandrescu, C. Dasanu, 2007, Southern medical journal.

Systemic lupus erythematosus associated with paclitaxel use in the treatment of ovarian cancer.

D. Alexandrescu, C. Dasanu, 2008, Southern medical journal.

Malignant melanoma in African-Americans.

D. Alexandrescu, C. Dasanu, F. Kabigting, 2009, Dermatology online journal.

Intravenous ascorbic acid to prevent and treat cancer-associated sepsis?

Michael J. González, J. Koropatnick, C. Chen, 2011, Journal of Translational Medicine.

Evolving strategies for the management of hand-foot skin reaction associated with the multitargeted kinase inhibitors sorafenib and sunitinib.

H. Kong, A. Hauschild, M. Atkins, 2008, The oncologist.

The influence of parental age and gender on anticipation in familial B-Cell malignancies

P. Wiernik, D. Alexandrescu, 2007, Medical oncology.

Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree

P. Wiernik, D. Alexandrescu, Alexandria Garino, 2006, Leukemia & lymphoma.

Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemia

P. Wiernik, D. Alexandrescu, 2008, Medical oncology.

Melanoma-specific marker expression in skin biopsy tissues as a tool to facilitate melanoma diagnosis.

Yixin Wang, T. Jatkoe, Haiying Wang, 2010, The Journal of investigative dermatology.

Risk for second nonlymphoid neoplasms in chronic lymphocytic leukemia.

D. Alexandrescu, C. Dasanu, 2007, MedGenMed : Medscape general medicine.

Mitoxantrone, vinblastine and CCNU: long-term follow-up of patients treated for advanced and poor-prognosis Hodgkin's disease

J. Dutcher, P. Wiernik, D. Alexandrescu, 2006, Leukemia & lymphoma.

Rapidly fatal acute ATLL emerging after methotrexate therapy for disseminated psoriasis.

T. Ichim, D. Alexandrescu, C. Dasanu, 2012, Clinical lymphoma, myeloma & leukemia.

Malignant Melanoma in Pigmented Skin: Does the Current Interventional Model Fit a Different Clinical, Histologic, and Molecular Entity?

T. Ichim, D. Alexandrescu, C. Dasanu, 2013, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

New frontiers in laser surgery.

E. Ross, D. Alexandrescu, 2012, Seminars in cutaneous medicine and surgery.

Selective Laser Targeting of Skin Cancers

E. Ross, D. Alexandrescu, 2012 .

Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome associated with high-dose interleukin-2 for the treatment of metastatic melanoma.

J. Dutcher, P. Wiernik, D. Alexandrescu, 2005, Journal of immunotherapy.

Bilateral Leser-Trélat Sign Mirroring Lung Adenocarcinoma with Early Metastases to the Contralateral Lung

D. Alexandrescu, C. Dasanu, 2009, Southern medical journal.

Pseudoscleroderma possibly induced by intravesical instillation of mitomycin C.

D. Alexandrescu, F. Azevedo, A. Mota, 2010, Journal of the American Academy of Dermatology.

IFN-conditioned dendritic cells for the therapy of melanoma: what is missing?

F. Marincola, T. Ichim, N. Riordan, 2011, Journal of immunotherapy.

Strokes after intravenous gamma globulin: Thrombotic phenomenon in patients with risk factors or just coincidence?

J. Dutcher, J. Hughes, P. Wiernik, 2005, American journal of hematology.

Steroid-responsive inclusion body myositis associated with endometrial cancer.

P. Wiernik, D. Alexandrescu, D. Wolfe, 2005, Clinical and experimental rheumatology.

Chronic Lymphocytic Leukemia Presenting with Cholecystitis-Like Symptoms and Gallbladder Wall Invasion

T. Ichim, D. Alexandrescu, C. Dasanu, 2010, Southern medical journal.

A case of prekallikrein deficiency resulting in severe recurrent mucosal hemorrhage.

D. Alexandrescu, C. Dasanu, 2009, The American journal of the medical sciences.

Unusually large colon cancer cutaneous and subcutaneous metastases occurring in resection scars.

P. Kelemen, P. Wiernik, D. Alexandrescu, 2005, Dermatology online journal.

Acute retinal pigment epithelial detachment secondary to pamidronate administration

D. Alexandrescu, C. Dasanu, 2009, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Small Cell Lung Cancer with Paraneoplastic Lipase Production

T. Ichim, B. Lahiri, D. Alexandrescu, 2010, Southern medical journal.

Carboplatin—gemcitabine in the therapy of advanced ovarian cancer: dose reduction consideration

T. Herzog, D. Alexandrescu, C. Dasanu, 2010, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Sea urchin granuloma secondary to Strongylocentrotus purpuratus and Strongylocentrotus franciscanus.

D. Alexandrescu, S. Kempiak, Filamer D. Kabigting, 2009, Dermatology online journal.

Autologous stromal vascular fraction cells: a tool for facilitating tolerance in rheumatic disease.

T. Ichim, W. Min, N. Riordan, 2010, Cellular immunology.

New frontiers in laser surgery.

E. Ross, D. Alexandrescu, 2012, Seminars in cutaneous medicine and surgery.

Persistent cutaneous hyperpigmentation after tyrosine kinase inhibition with imatinib for GIST.

D. Alexandrescu, C. Dasanu, H. Farzanmehr, 2008, Dermatology online journal.